Cost‐effectiveness of Anti‐CD19 chimeric antigen receptor T‐Cell therapy in pediatric relapsed/refractory B‐cell acute lymphoblastic leukemia. A societal view
Frederick W. Thielen(University Medical Center Freiburg), Annemieke van Dongen‐Leunis(Erasmus University Rotterdam), Alexander M. M. Arons(Novartis (Netherlands)), Judith R. Ladestein(Novartis (Netherlands)), Peter M. Hoogerbrugge(Helios Klinikum Emil von Behring)
Cited by 42
Related Papers
Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial
|Journal of Clinical Oncology|2015|419
Aspirin with or without Clopidogrel after Transcatheter Aortic-Valve Implantation
|New England Journal of Medicine|2020|418
Anticoagulation with or without Clopidogrel after Transcatheter Aortic-Valve Implantation
|New England Journal of Medicine|2020|345
Online focus groups as a tool to collect data in hard-to-include populations: examples from paediatric oncology
|BMC Medical Research Methodology|2009|237